Dean Lloyd H reported grant involving 6,792 shares of Progyny, Inc. at $0.00 for $0 on May 21, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed May 26, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
6,792Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
26,519Direct
Trade date
May 21, 2026Grant
Filed
May 26, 2026, 4:24 PM ET5-day reporting delay
Accession
0001551306-26-000105Code A · Transaction 385993
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 21, 2026Grant28,203$0.00$0Trade 385994
2 transaction rows in this filing. Joint filers share the same rows.

PGNY price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PGNY · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −28%1w ago −8.7%1d ago +2.4%
Returns since7d +0.3%30d +9.3%90d +1.6%180d1y

Footnotes in full

F1: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. F2: The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.